Followers | 1082 |
Posts | 26724 |
Boards Moderated | 12 |
Alias Born | 01/11/2016 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 03, 2019 4:42:14 PM
$PTI 10% We get 10% on Homozygous, this will match 10% Vertex had, and this will be major win.
We had 8% on 14 day compared to Vertex 10% over 28 day measures at 24 week high dosages, we were running low dosage, and we only tested ours on 8 patients that were sick not hand picked like Vertex.
Vertex achieved 14% on Heterozygous which is also very possible we reach this.
Remember they are conducting test using 30 patients Homozygous and 30 patients Heterozygous, Homozygous being the most difficult to treat.
12
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM